Researchers are excited about Retatrutide , a novel dual agonist showing promising results in clinical trials for body loss . It works by modulating several systems: GLP-1 and GIP, that , when activated , support influence hunger and enhance metabolism . Initial observations suggest considerable weight loss and potential improvements for individual